Quaternary prevention: reviewing the concept

References

• Clark D, MacMahon B. Preventive medicine. Boston (MA): Little, Brown & Co; 1967.
   Google Scholar
• Nightengale E, Cureton M, Kalmar V. Perspectives on health promotion and disease prevention in the United States. Washington (DC): Institute of Medicine, National Academy of Sciences; 1978.
   Google Scholar
• Bentzen N. Wonca dictionary of general/family practice. Copenhagen: Manedsskrift for Praktisk Laegergerning; 2003.
   Google Scholar
• Hudson B, Zarifeh A, Young L, et al. Patients’ expectations of screening and preventive treatments. Ann Fam Med. 2012;10:495–502.
   PubMed Web of Science ®Google Scholar
• Krouss M, Croft L, Morgan DJ. Physician understanding and ability to communicate harms and benefits of common medical treatments. JAMA Intern Med. 2016;176:1565–1567.
   PubMed Web of Science ®Google Scholar
• Jamoulle M. Information et informatisation en médecine générale. Inf.-G-Iciens. Namur (Belgium): Presses Universitaires de Namur; 1986. p. 193–209.
   Google Scholar
• Kuehlein T, Sghedoni D, Visentin G, et al. Quaternary prevention: a task of the general practitioner. Prim Care. 2010;10:350–354.
   Google Scholar
• Wijnans L, Lecomte C, de Vries C, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine. 2013;31:1246–1254.
   PubMed Web of Science ®Google Scholar
• Krogsboll LT, Jorgensen KJ, Gronhoj Larsen C, et al. General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ. 2012;345:e7191–e7191.
   PubMed Web of Science ®Google Scholar
• Brotons C, Bulc M, Sammut MR, et al. Attitudes toward preventive services and lifestyle: the views of primary care patients in Europe. The EUROPREVIEW patient study. Fam Pract. 2012;29(Suppl 1):i168–i176.
   PubMed Web of Science ®Google Scholar
• Martins C, Azevedo LF, Ribeiro O, et al. A population-based nationwide cross-sectional study on preventive health services utilization in Portugal—what services (and frequencies) are deemed necessary by patients? PLoS One. 2013;8:e81256.
   PubMed Web of Science ®Google Scholar
• Welch HG, Schwartz LM, Woloshin S, Overdiagnosed: making people sick in the pursuit of health. Boston (Mass): Beacon Press; 2011.
   Google Scholar
• Heleno B, Thomsen MF, Rodrigues DS, et al. Quantification of harms in cancer screening trials: literature review. BMJ. 2013;347:f5334
   PubMed Web of Science ®Google Scholar
• Harris RP, Sheridan SL, Lewis CL, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med. 2014;174:281–285.
   PubMed Web of Science ®Google Scholar
• Gérvas J. Quaternary prevention in the elderly. Rev Esp Geriatr Gerontol. 2012;47:266–269.
   PubMedGoogle Scholar
• Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–788.
   PubMed Web of Science ®Google Scholar
• Boardman HMP, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;CD002229. DOI:10.1002/14651858.CD002229.pub4
   PubMed Web of Science ®Google Scholar
• Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013;CD008143. DOI:10.1002/14651858.CD008143.pub3
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559.
   PubMed Web of Science ®Google Scholar
• Moynihan R, Doran E, Henry D. Disease mongering is now part of the global health debate. PLoS Med. 2008;5:e106.
   PubMed Web of Science ®Google Scholar
• Brodersen J, Schwartz LM, Woloshin S. Overdiagnosis: how cancer screening can turn indolent pathology into illness. APMIS Acta Pathol Microbiol Immunol Scand. 2014;122:683–689.
   PubMed Web of Science ®Google Scholar
• Jamoulle M. Quaternary prevention: first, do not harm. Rev Bras Med Fam E Comunidade. 2015;10:1.
   Google Scholar
• Cardoso RV. Quaternary prevention: a gaze on medicalization in the practice of family doctors. Rev Bras Med Fam Comunidade. 2015;10:1.
   Google Scholar
• Cuba Fuentes MS, Zegarra Zamalloa CO, Reichert S, et al. Attitudes, perceptions and awareness concerning quaternary prevention among family doctors working in the social security system, Peru: a cross-sectional descriptive study. Medwave. 2016;16:e6433.
   PubMed Web of Science ®Google Scholar
• Jamoulle M. Quaternary prevention, an answer of family doctors to overmedicalization. Int. J. Health Policy Manag. 2015;4:61–64.
   PubMed Web of Science ®Google Scholar
• Widmer D, Herzig L, Jamoulle M. Quaternary prevention: is acting always justified in family medicine? Rev Med Suisse. 2014;10:1052–1056.
   PubMedGoogle Scholar
• Bae J-M, Jamoulle M. Primary care physicians’ action plans for responding to results of screening tests based on the concept of quaternary prevention. J Prev Med Pub Health. 2016;49:343–348.
   PubMedGoogle Scholar
• Widmer D. Care and do not harm: possible misunderstandings with quaternary prevention (P4) comment on ‘Quaternary prevention, an answer of family doctors to over medicalization’. Int J Health Policy Manag. 2015;4:561–563.
   PubMed Web of Science ®Google Scholar
• Pandve HT. Quaternary prevention: need of the hour. J Family Med Prim Care. 2014;3:309–310.
   PubMedGoogle Scholar
• Wagner H. Quaternary prevention and the challenges to develop a good practice comment on ‘Quaternary prevention, an answer of family doctors to overmedicalization’. Int J Health Policy Manag. 2015;4:557–558.
   PubMed Web of Science ®Google Scholar